Sedation with propofol for flexible bronchoscopy in children

Area of Science:

• Pediatric Pulmonology
• Anesthesiology
• Critical Care Medicine

Background:

• Flexible bronchoscopy (FB) is a common diagnostic tool in pediatric pulmonology.
• Sedation is essential for performing FB in children.
• Intravenous propofol (IVP) is a widely used anesthetic agent for procedural sedation.

Purpose of the Study:

• To evaluate the safety and efficacy of intravenous propofol (IVP) for flexible bronchoscopy (FB) in pediatric patients.
• To report on the cardio-respiratory complications associated with IVP sedation during FB in children.

Main Methods:

• A retrospective review of 103 pediatric patients undergoing FB under IVP sedation.
• Data collected included demographics, diagnoses, procedural times (induction, sedation, procedure, discharge), IVP dosage, and cardio-respiratory parameters (HR, RR, BP, SpO2).
• Statistical analysis was performed to assess correlations and significance of findings.

Main Results:

• Airway abnormalities were diagnosed in 90% of patients, leading to therapy changes in 66%.
• IVP induction dose (ID) varied by age group, with older children requiring higher doses.
• Statistically significant but clinically insignificant drops in systolic and diastolic blood pressure were observed; no patient experienced hypotension, significant hypoxia, or required intubation.

Conclusions:

• Intravenous propofol (IVP) is a safe and effective sedation method for pediatric flexible bronchoscopy (FB).
• FB under IVP sedation in children is associated with a low incidence of cardio-respiratory complications.
• IVP facilitates successful FB procedures in pediatric patients.